<DOC>
	<DOC>NCT00479505</DOC>
	<brief_summary>This is a 12 week study in which different doses of UK-369,003 will be administered to patients with a diagnosis of overactive bladder. Patients will complete a series of questionnaires before treatment, during treatment and after treatment, to assess whether UK-369,003 has improved their symptoms of overactive bladder and erectile function.</brief_summary>
	<brief_title>Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<criteria>Male subjects aged 18 years and above documented clinical diagnosis of overactive bladder with urinary frequency &gt;= 8 times / 24 hours and number of urgency episodes &gt; 1 episode / 24 hours. Neurological diseases known to affect bladder function. Urinary tract infection.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>